Live
- Bhupesh Baghel threatens defamation case over allegations in Bitcoin scam
- I want to have that chance of playing in IPL, says Swastik Chikara ahead of mega auction
- Damson Technologies Inaugurates State-of-the-Art Manufacturing Facility in Ahmedabad with Rs. 200 Crore planned Investment
- Waqf row: BJP stages protest condemning land grab in Karnataka
- President Droupadi Murmu Graces Koti Deepotsavam in Hyderabad
- South Korean court sentences ex-fiance of Olympic fencing medalist to 13-yr prison term
- Posani Krishna Murali Announces Exit from Politics
- Allu Arjun and Sreeleela to Ignite the Stage with Pushpa-2’s Special Song
- World Television Day 2024: From B&W Beginnings to Smart TVs and Their Role in Shaping Elections
- Bihar: Kaimur residents buy cheap medicines from Jan Aushadhi Kendras, thanks govt
Scientist finds non-invasive method of cancer detection
Scientist finds non-invasive method of cancer detection
During the study, it was shown that circulating cell free DNA could be used as an effective marker to evaluate tumour burden in the patients, both in untreated and treated individuals. It also shows that during concurrent chemo-radiotherapy, ccfDNA load disappeared and after six months of follow up, appeared back due to distant metastasis.
Dr Samrendra Kumar Singh, assistant professor, School of Biotechnology in the Institute of Science, Banaras Hindu University (BHU), has found a non-invasive method to diagnose cervical cancer in patients.
His findings have been published in the 'Journal of Cancer Research and Therapeutics (JCRT)'. The study finds a cost-effective and specific method for early detection, treatment monitoring, the status of residual disease and distant tumour metastasis in cervical cancer patients. The study was undertaken in collaboration with the department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, BHU.
He said that the sensitivity and specificity of this method and short half-life of ccfDNA makes this method reliable and potent as an affordable and real-time biomarker for detecting tumour burden in cervical carcinoma patients. The study has also shown a way to follow up prognostic outcomes of medication/surgery by using blood samples from cancer patients.
